Literature DB >> 25131853

Isolated mesenteric CD20-positive myeloid sarcoma.

Maro Ohanian1, Richard Sheng Poe Huang2, Tatiana V Yakoushina2, Zeev Estrov1, Harinder Juneja3, Lei Chen2, Modupe Idowu4, Lynne V Abruzzo5.   

Abstract

Entities:  

Keywords:  Abdominal mass; Acute myeloid leukemia; Extramedullary; Misdiagnosis; Myeloid sarcoma; Myeloperoxidase

Mesh:

Substances:

Year:  2014        PMID: 25131853      PMCID: PMC4257057          DOI: 10.1016/j.clml.2014.06.027

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN: 2152-2669


× No keyword cloud information.
  14 in total

1.  Mesenteric chloroma with t(16;16) followed by acute myelomonocytic leukemia with clonal evolution.

Authors:  Gudrun Göhring; Miriam Erlacher; Miriam van Buiren; Eva Jüttner; Charlotte M Niemeyer; Brigitte Schlegelberger
Journal:  Cancer Genet Cytogenet       Date:  2007-12

2.  The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.

Authors:  H S Khalidi; L J Medeiros; K L Chang; R K Brynes; M L Slovak; D A Arber
Journal:  Am J Clin Pathol       Date:  1998-02       Impact factor: 2.493

Review 3.  Is acute myeloid leukemia a liquid tumor?

Authors:  Maro Ohanian; Stefan Faderl; Farhad Ravandi; Naveen Pemmaraju; Guillermo Garcia-Manero; Jorge Cortes; Zeev Estrov
Journal:  Int J Cancer       Date:  2013-02-04       Impact factor: 7.396

4.  Solitary preleukemic granulocytic sarcoma as a cause of small bowel obstruction.

Authors:  Sang Hun Jung; Hee Cheol Kim; Chang Sik Yu; Jin Cheon Kim
Journal:  Gut Liver       Date:  2007-06-30       Impact factor: 4.519

5.  c-Kit (CD117) reactivity in extramedullary myeloid tumor/granulocytic sarcoma.

Authors:  J Chen; R R Yanuck; S L Abbondanzo; W S Chu; N S Aguilera
Journal:  Arch Pathol Lab Med       Date:  2001-11       Impact factor: 5.534

6.  Prognostic factors of treatment outcomes in patients with granulocytic sarcoma.

Authors:  Tsung-Yu Lan; Dong-Tsamn Lin; Hwei-Fang Tien; Rong-Sen Yang; Chih-Yu Chen; Karl Wu
Journal:  Acta Haematol       Date:  2009-10-30       Impact factor: 2.195

7.  Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia.

Authors:  Apostolia-Maria Tsimberidou; Hagop M Kantarjian; Sijin Wen; Michael J Keating; Susan O'Brien; Mark Brandt; Sherry Pierce; Emil J Freireich; L Jeffrey Medeiros; Elihu Estey
Journal:  Cancer       Date:  2008-09-15       Impact factor: 6.860

8.  Extramedullary myeloid cell tumors. An immunohistochemical and morphologic study of 28 cases.

Authors:  S T Traweek; D A Arber; H Rappaport; R K Brynes
Journal:  Am J Surg Pathol       Date:  1993-10       Impact factor: 6.394

9.  Management of extramedullary leukemia as a presentation of acute myeloid leukemia.

Authors:  Samuel J Slomowitz; Paul J Shami
Journal:  J Natl Compr Canc Netw       Date:  2012-09       Impact factor: 11.908

10.  Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study.

Authors:  Borislav A Alexiev; Wenle Wang; Yi Ning; Saranya Chumsri; Ivana Gojo; William H Rodgers; Sanford A Stass; Xianfeng F Zhao
Journal:  Diagn Pathol       Date:  2007-10-31       Impact factor: 2.644

View more
  3 in total

1.  Eosinophilic nucleoli.

Authors:  Radhika M Bavle
Journal:  J Oral Maxillofac Pathol       Date:  2014-05

2.  Peritoneal Myeloid Sarcoma in a Patient Treated for a Testicular Seminoma.

Authors:  Raffaele Longo; Véronique Dorvaux; Eric Chatelain; Philippe Quétin; Francesca Plastino; Nada Eid; Nathalie Marcon; Laurent Hennequin; Marco Campitiello
Journal:  Am J Case Rep       Date:  2018-06-29

3.  The transformation of isolated gastric myeloid sarcoma into acute myeloid leukemia presenting with a complex karyotype and TLS-ERG gene fusion: A case report.

Authors:  Lu Gao; Yan Xu; Zuguo Tian; Junxiu Xia; Zhong Yuan; Di Chen; Mingqiang Ren
Journal:  Medicine (Baltimore)       Date:  2022-05-27       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.